These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29103029)

  • 1. Tumor tissue katanin P60 expression correlates with lymph node metastasis and worse prognosis in patients with breast cancer: A cohort study.
    Zuo L; Ying JS; Zhang FC; Xu YC
    Cancer Biomark; 2018 Feb; 21(2):425-432. PubMed ID: 29103029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Katanin P80 expression correlates with lymph node metastasis and worse overall survival in patients with breast cancer.
    Li X; Liu J; Shi PF; Fu P
    Cancer Biomark; 2018; 23(3):363-371. PubMed ID: 30223388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer.
    Wang L; Tantai J; Zhu X
    World J Surg Oncol; 2020 Jul; 18(1):157. PubMed ID: 32631334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Katanin P60 and P80 in papillary thyroid carcinoma patients: Indicators for exacerbated tumor features and worse disease-free survival.
    Chen Q; Lin F; Lin E; Huang Q; Wu G
    J Clin Lab Anal; 2020 Dec; 34(12):e23502. PubMed ID: 33274499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
    Ye Q; Zhang M; Yin Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
    Yardley DA; Kaufman PA; Huang W; Krekow L; Savin M; Lawler WE; Zrada S; Starr A; Einhorn H; Schwartzberg LS; Adams JW; Lie Y; Paquet AC; Sperinde J; Haddad M; Anderson S; Brigino M; Pesano R; Bates MP; Weidler J; Bosserman L
    Breast Cancer Res; 2015 Mar; 17(1):41. PubMed ID: 25886996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.
    Lim ST; Choi JE; Kim SJ; Kim HA; Kim JY; Park HK; Suh YJ
    Breast Cancer Res Treat; 2016 Apr; 156(3):473-483. PubMed ID: 27041335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
    Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
    Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
    Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
    Zhang JM; Wei K; Jiang M
    Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
    Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
    J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of anatomic and prognostic stages of breast cancer according to the 8th edition of the TNM staging system - Retrospective analysis based on data from deceased patients once diagnosed with breast cancer].
    Zombori T; Lehóczky L; Cserni B; Nyári T; Cserni G
    Orv Hetil; 2017 Sep; 158(35):1373-1381. PubMed ID: 28847177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.